An immune-related gene has now been tied to a rare inherited neurological disorder, revealing an overlooked pathway in the nervous system.

PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...

STOCKHOLM, SE / ACCESS Newswire / March 19, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, fo ...

A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified ...

Despite modern high-throughput sequencing, the genetic cause of most rare movement disorders remains unclear. A research team in Bochum and Tübingen has now solved one piece of the puzzle: The ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ('Reviva” or the 'Company”), a late-stage pharmaceutical company ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ('Reviva” or the 'Company”), a late-stage pharmaceutical company ...

Praxis Precision Medicines develops clinical-stage therapies for neurological disorders, targeting major unmet needs in CNS therapeutics.

In the historical context, psychedelics reveal a spectrum of applications, ranging from spiritual and recreational use to ...

Have you ever noticed your reptile seemingly "stargazing" with its posture? This is actually a sign of a serious health ...

Dissociation often shows up in therapy long before it’s recognized. Here are five subtle signs clinicians may already be seeing but do not yet have a language for.

NEW YORK and SAN SEBASTIÁN, Spain, March 17, 2026 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...